MLBPA head: Treatment better option than suspension for opioids
Major League Baseball Players Association executive director Tony Clark believes that changes to MLB's drug agreement should focus on treatment, and not suspensions, for players who test positive for opioids.
"We believe wholeheartedly, as we always have, that the treatment option and not discipline is the best route to go," Clark said Wednesday at an annual union meeting with all 30 player representatives, according to Steven Wine of The Associated Press.
Clark also said adding testing for opioids to the drug agreement is under discussion between the MLBPA and the league. He says that change will likely come this offseason.
"I'm pretty confident that’s where we're going," Clark said.
Opioids have been a major talking point around baseball since Los Angeles Angels pitcher Tyler Skaggs died from an overdose in July. It was later reported the 27-year-old had been abusing oxycodone for years, and that an Angels employee was providing the drug to him.
HEADLINES
- Ohtani Ks 10 as Dodgers complete sweep to hand Mets 8th straight loss
- Angels botch infield popup in 9th in agonizing loss to Yankees
- Dodgers shattered MLB's spending record at over $514M in 2025
- Braves' Elder sports 0.77 ERA as hot start to season continues
- Report: MLBPA shakeup continues as COO, head of HR leave union